We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
Revelation Pharma Completes Sixteenth Acquisition – Adding Rock Valley Compounding Pharmacy to the Revelation Pharma Network
TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the sixteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Rock Valley Compounding Pharmacy located in Rockford, Illinois. Rock Valley takes immense pride in offering high-quality, specialized treatments while collaborating closely with prescribing physicians to guarantee the best possible health outcomes for each patient.
The acquisition of Rock Valley Compounding Pharmacy represents Revelation’s ongoing goal to establish a nationwide network of 503A and 503B compounding pharmacies. Compounding pharmacies create high-quality, personalized prescriptions to address a particular therapeutic need, frequently improving the quality of life for patients.
Revelation Pharma Completes Fifteenth Acquisition – Purchases Stanley Specialty Pharmacy
TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the fifteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Stanley Specialty Pharmacy located in Charlotte, North Carolina. Stanley Specialty Pharmacy is a PCAB accredited, 503A compounding pharmacy that is dedicated to enhancing the quality of patients’ lives through creative, individualized pharmaceutical treatments and incomparable customer care.
The purchase of Stanley Specialty Pharmacy signifies Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life.
“As a compounding industry veteran, I have witnessed the numerous changes
TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the fourteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Markers Compounding Pharmacy located in Mount Vernon, Washington. Makers Compounding Pharmacy is a PCAB accredited, 503A compounding pharmacy that offers compounded preparations to each individual patient and while working alongside their health care provider to specialize the delivery method to fit the patient’s lifestyle and special needs.
The purchase of Makers Compounding Pharmacy signifies Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life.
TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the thirteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Community Clinical Pharmacy located in Mesa, Arizona. Community Clinical Pharmacy is a 503A compounding pharmacy with more than 42 years of expertise, offering patients and healthcare professionals the highest quality compounded preparations to help optimize health.
The purchase of Community Clinical Pharmacy highlights Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life.
“We’re excited to join the Revelation family of pharmacies. Through Revelation’s vision and market-leading expertise, we look forward to Community Clinical Pharmacy’s ability to help our community
